Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial
Author:
Affiliation:
1. University of Houston College of Pharmacy , Houston, Texas , USA
2. The University of Texas Health Science Center at Houston School of Public Health , Houston, Texas , USA
3. Acurx Pharmaceuticals, Inc , Staten Island, New York , USA
Abstract
Funder
Acurx Pharmaceuticals
University of Houston
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac096/42974424/ciac096.pdf
Reference22 articles.
1. Changes in prevalence of health care-associated infections in U.S. Hospitals.;Magill;N Engl J Med,2018
2. Burden of Clostridium difficile infection in the United States.;Lessa;N Engl J Med,2015
3. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults.;Johnson;Clin Infect Dis,2021
4. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.;Shen;J Antimicrob Chemother,2020
5. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.;Gonzales-Luna;Anaerobe,2021
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cas clinique commenté : infection à Clostridium difficile chez un patient avec hypertension portale;Anesthésie & Réanimation;2024-02
2. European Practice for CDI Treatment;Advances in Experimental Medicine and Biology;2024
3. Clostridium difficile infection in pediatric patients (Review);Biomedical Reports;2023-12-08
4. Clostridioides difficile resistance to antibiotics, including post-COVID-19 data;Expert Review of Clinical Pharmacology;2023-08-29
5. Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy;Pediatrics;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3